Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


ANDA Holder Fee Will Start With Industry-Driven Database 'Clean-Up'

Executive Summary

FDA is again relying on sponsor self-reporting as it launches GDUFA II.


Related Content

Generic User Fee Hikes Could Disrupt US FDA Drug Pricing Campaign
Generic Industry Consolidating But Still Mysterious
GDUFA II: More Than 2,000 ANDAs Remain Unclaimed, Large Firms Still Dominate
Generic Industry Consolidation Illustrated In ANDA Holder List
GDUFA II: Industry Shares Stage With FDA
User Fees For FY 2017 Make Sponsors Happy, Manufacturers Sad
GDUFA: Will Industry Self-Identification Push Lengthen The Backlog?


What to read next




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts